Abstract
Nuclear factor-kappa B (NF-κB) is a critical transcription factor for the inducible expression of multiple genes involved in inflammation. NF-κB is sequestered in the cytoplasm by inhibitory IκB proteins. Extracellular stimuli, notably interleukin-1β (IL-1β) and tumor necrosis factorα (TNF-α) activate NF-κB nuclear translocation via IκB phosphorylation and degradation. Since previous reports suggest that the short chain fatty acid butyrate has antiinflammatory properties, the effects of butyrate on NF-κB nuclear translocation in human epithelial cells (HeLa229) were tested. In cells pretreated with butyrate, a time- and dose-dependent inhibition of IL-1β-mediated NF-κB nuclear translocation was observed. However, IκBα phosphorylation and degradation occurred rapidly in both butyrate pretreated and nonpretreated cells, respectively. These data indicate that inhibition of IL-1β-induced NF-κB activation by butyrate does not require an intact IκBα protein.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Bugaut M: Occurrence, absorption and metabolism of short chain fatty acids in the digestive tract of mammals. Comp Biochem Physiol B 86:439–472, 1987
Scheppach W, Sommer H, Kirchner T, Paganelli GM, Bartram P, Christl S, Richter F, Dusel G, Kasper H: Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterology 103:51–56, 1992
Senagore AJ, MacKeigan JM, Scheider M, Ebrom JS: Shortchain fatty acid enemas: A cost-effective alternative in the treatment of nonspecific proctosigmoiditis. Dis Colon Rectum 35:923–927, 1992
Vernia P, Marcheggiano A, Caprilli R, Frieri G, Corrao G, Valpiani D, Di Paolo MC, Paoluzi P, Torsoli A: Short-chain fatty acid topical treatment in distal ulcerative colitis. Aliment Pharmacol Ther 9:309–313, 1995
Breuer RI, Buto SK, Christ ML, Bean J, Vernia P, Paoluzi P, Di Paolo MC, Caprilli R: Rectal irrigation with short-chain fatty acids for distal ulcerative colitis. Dig Dis Sci 36:185–187, 1991
Steinhart AH, Brzezinski A, Baker JP: Treatment of refractory ulcerative proctosigmoiditis with butyrate enemas. Am J Gastroenterol 89:179–183, 1994
Vernia P, Cittadini M, Caprilli R, Torsoli A: Topical treatment of refractory distal ulcerative colitis with 5-ASA and sodium butyrate. Dig Dis Sci 40:305–307, 1995
Patz J, Jacobsohn WZ, Gottschalk-Sabag S, Zeides S, Braverman DZ: Treatment of refractory distal ulcerative colitis with short chain fatty acid enemas. Am J Gastroenterol 91:731–734, 1996
Harig JM, Soergel KH, Komorowski RA, Wood CM: Treatment of diversion colitis with short-chain-fatty acid irrigation. N Engl J Med 320:23–28, 1989
Pinto A, Fidalgo P, Cravo M, Midoes J, Chaves P, Rosa J, dos Anjos Brito M, Leitao CN: Short chain fatty acids are effective in short-term treatment of chronic radiation proctitis: randomized, double-blind, controlled trial. Dis Colon Rectum 42:788–796, 1999
Kvale D, Brandtzaeg P: Constitutive and cytokine induced expression of HLA molecules, secretory component, and intercellular adhesion molecule-1 is modulated by butyrate in the colonic epithelial cell line HT-29. Gut 36:737–742, 1995
Siebenlist U, Franzoso G, Brown K: Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol 10:405–455, 1994
Baeuerle PA, Baltimore D: NF-kappa B: Ten years after. Cell 87:13–20, 1996
Barnes PJ, Karin M: Nuclear factor-kappaB: A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336:1066–1071, 1997
Schutze S, Potthoff K, Machleidt T, Berkovic D, Wiegmann K, Kronke M: TNF activates NF-kappa B by phosphatidylcholinespecific phospholipase C-induced “acidic” sphingomyelin breakdown. Cell 71:765–776, 1992
Dinarello CA: Interleukin-1 and tumor necrosis factor: effector cytokines in autoimmune diseases. Semin Immunol 4:133–145, 1992
Arend WP, Dayer JM: Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis. Arthritis Rheum 38:151–160, 1995
Baldwin AS, Jr.: The NF-kappa B and I kappa B proteins: New discoveries and insights. Annu Rev Immunol 14: 649–683, 1996
Beg AA, Finco TS, Nantermet PV, Baldwin AS Jr: Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: A mechanism for NF-kappa B activation. Mol Cell Biol 13:3301–3310, 1993
Palombella VJ, Rando OJ, Goldberg AL, Maniatis T: The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B. Cell 78:773–785, 1994
Brown K, Gerstberger S, Carlson L, Franzoso G, Siebenlist U: Control of I kappa B-alpha proteolysis by site-specific, signalinduced phosphorylation. Science 267:1485–1488, 1995
Thompson JE, Phillips RJ, Erdjument-Bromage H, Tempst P, Ghosh S: I kappa B-beta regulates the persistent response in a biphasic activation of NF-kappa B. Cell 80:573–582, 1995
Egan LJ, Mays DC, Huntoon CJ, Bell MP, Pike MG, Sandborn WJ, Lipsky JJ, McKean DJ: Inhibition of interleukin-1-stimulated NF-kappaB RelA/p65 phosphorylation by mesalamine is accompanied by decreased transcriptional activity. J Biol Chem 274:26448–26453, 1999
Inan MS, Rasoulpour RJ, Yin L, Hubbard AK, Rosenberg DW, Giardina C: The luminal short-chain fatty acid butyrate modulates NF-kappaB activity in a human colonic epithelial cell line. Gastroenterology 118:724–734, 2000
Wahl C, Liptay S, Adler G, Schmid RM:Sulfasalazine: A potent and specific inhibitor of nuclear factor kappa B. J Clin Invest 101:1163–1174, 1998
de Martin R, Vanhove B, Cheng Q, Hofer E, Csizmadia V, Winkler H, Bach FH: Cytokine-inducible expression in endothelial cells of an I kappa B alpha-like gene is regulated by NF kappa B. Embo J 12:2773–2779, 1993
Neurath MF, Pettersson S, Meyer zum Buschenfelde KH, Strober W: Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice. Nat Med 2: 998–1004, 1996
Kopp E, Ghosh S: Inhibition of NF-kappa B by sodium salicylate and aspirin. Science 265:956–959, 1994
Pierce JW, Read MA, Ding H, Luscinskas FW, Collins T: Salicylates inhibit I kappa B-alpha phosphorylation, endothelial- leukocyte adhesion molecule expression, and neutrophil transmigration. J Immunol 156: 3961–3969, 1996
Yan F, Polk DB: Aminosalicylic acid inhibits IkappaB kinase alpha phosphorylation of IkappaBalpha in mouse intestinal epithelial cells. J Biol Chem 274:36631–36636, 1999
Wilson L, Szabo C, Salzman AL: Protein kinase C-dependent activation of NF-kappaB in enterocytes is independent of IkappaB degradation. Gastroenterology 117: 106–114, 1999
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lũhrs, H., Gerke, T., Boxberger, F. et al. Butyrate Inhibits Interleukin-1-Mediated Nuclear Factor-Kappa B Activation in Human Epithelial Cells. Dig Dis Sci 46, 1968–1973 (2001). https://doi.org/10.1023/A:1010699418024
Issue Date:
DOI: https://doi.org/10.1023/A:1010699418024